Wells Fargo’s Firefly Neuroscience AIFF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-200
Closed -$566 7467
2025
Q2
$566 Hold
200
﹤0.01% 6363
2025
Q1
$786 Sell
200
-322
-62% -$1.48K ﹤0.01% 6254
2024
Q4
$1.38K Sell
522
-165
-24% -$512 ﹤0.01% 6231
2024
Q3
$2.09K Buy
687
+1
+0.1% +$5 ﹤0.01% 6049
2024
Q2
$4.26K Buy
686
+682
+17,050% +$5.08K ﹤0.01% 5902
2024
Q1
$42 Hold
4
﹤0.01% 6877
2023
Q4
$20 Hold
4
﹤0.01% 7227
2023
Q3
$28 Buy
4
+1
+33% +$10 ﹤0.01% 7099
2023
Q2
$31 Hold
3
﹤0.01% 7190
2023
Q1
$28 Hold
3
﹤0.01% 7285
2022
Q4
$46 Hold
3
﹤0.01% 7040
2022
Q3
$0 Buy
3
+1
+50% +$37 ﹤0.01% 7520
2022
Q2
$0 Hold
2
﹤0.01% 7644
2022
Q1
$0 Buy
+2
New +$270 ﹤0.01% 7973

Other funds holding AIFF

Wells Fargo's AIFF Position: Q3 2025 in Review

Wells Fargo sold out of Firefly Neuroscience (AIFF) in Q3 2025, closing a stake of 200 shares — an estimated $566 sold.

Wells Fargo first reported a position in AIFF in Q1 2022 and held it in 14 quarters. The position peaked at $4.26K in Q2 2024. 18 funds tracked by Wall St. Rank hold AIFF as of Q3 2025.

  • Wells Fargo reported no remaining Firefly Neuroscience position as of Q3 2025 after selling out during the quarter.
  • Wells Fargo sold 200 Firefly Neuroscience shares in Q3 2025, an estimated $566.
  • Wells Fargo first reported a position in Firefly Neuroscience in Q1 2022 and held it in 14 quarters.
  • Wells Fargo's Firefly Neuroscience position peaked at $4.26K in Q2 2024.
  • 18 funds tracked by Wall St. Rank held Firefly Neuroscience as of Q3 2025.

Based on Wells Fargo's 13F filing for Q3 2025, filed 13 Nov 2025.